We are live on ! Find out more
XAGEW

Longevity Health Holdings, Inc. Warrant

Delisted

XAGEW was delisted on the 11th of September, 2025.

16 hedge funds and large institutions have $172K invested in Longevity Health Holdings, Inc. Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1616 (0)

1% less capital invested

Capital invested by funds: $174K → $172K (-$2.54K)

1.17% less ownership

Funds ownership: 10.89%9.72% (-1.2%)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
4
Closed
Calls
$11K
Puts
Net Calls
+$11K
Net Calls Change
-$3K

XAGEW Hedge Fund Activity: Q3 2024 in Review

16 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Warrant (XAGEW) for Q3 2024, worth a combined $172K — down 1.5% from $174K a quarter earlier.

Fund positioning in XAGEW was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was UBS Group, adding an estimated $738. The largest seller was Exos Asset Management, cutting an estimated $6.51K.

  • 16 institutional investors held Longevity Health Holdings, Inc. Warrant (XAGEW) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $172K of Longevity Health Holdings, Inc. Warrant stock for Q3 2024, down 1.5% quarter-over-quarter.
  • 0 funds opened new Longevity Health Holdings, Inc. Warrant positions in Q3 2024 and 0 closed out.
  • The largest Longevity Health Holdings, Inc. Warrant buyer in Q3 2024 was UBS Group, an estimated $738 added.
  • The largest Longevity Health Holdings, Inc. Warrant seller in Q3 2024 was Exos Asset Management, an estimated $6.51K sold.

Based on aggregated 13F filings for Q3 2024.